Endoscopic third ventriculostomy (ETV) was performed between July 1978 and July 1995 on 69 patients with hydrocephalus and myelomeningocele. Most of the patients had been previously shunted, although in 14 patients ETV was the initial treatment. Patient selection was based on preoperative imaging studies suggesting noncommunicating hydrocephalus. Only 2 patients exhibited transient hypothalamic dysfunction with complete resolution. Patients were assessed by their clinical status, imaging characteristics, and, in some cases, formal psychometric studies. The overall success rate was 72%, although selecting only patients who have been previously shunted or who were over 6 months of age at the time of endoscopy increases this to 80%. Our results indicate that ETV is a safe and effective means of treating hydrocephalus in the older spina bifida population and offers the hope of long-term, shunt-independent life for selected patients.

Keywords:
Endoscopy, Hydrocephalus, Pediatrics, Spina bifida
This content is only available via PDF.
© 1996 S. Karger AG, Basel
1996
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.